Other
2028
Biogen 2028 increased by 7.1% to $525.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 12.5%, from $600.00M to $525.00M. Over 3 years (FY 2020 to FY 2023), 2028 shows an upward trend with a 29.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026
How to read this metric
A declining trend in these annual projections indicates that the bank's historical acquisition costs are being successfully absorbed.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2028. It reflects the...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_398565Historical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $215.00M | $210.00M | $210.00M | $195.00M | $195.00M | $195.00M | $195.00M | $190.00M | $190.00M | $430.00M | $470.00M | $660.00M | $660.00M | $550.00M | $600.00M | $600.00M | $490.00M | $525.00M |
| QoQ Change | — | -2.3% | +0.0% | -7.1% | +0.0% | +0.0% | +0.0% | -2.6% | +0.0% | +126.3% | +9.3% | +40.4% | +0.0% | -16.7% | +9.1% | +0.0% | -18.3% | +7.1% |
| YoY Change | — | — | — | — | -9.3% | -7.1% | -7.1% | -2.6% | -2.6% | +120.5% | +141.0% | +247.4% | +247.4% | +27.9% | -9.1% | -9.1% | -10.9% | -12.5% |
Range$190.00M – $660.00M
CAGR+23.4%
Avg YoY Growth+51.0%
Median YoY Growth-4.9%
2028 at Other Companies
Frequently Asked Questions
- What is Biogen's 2028?
- Biogen (BIIB) reported 2028 of $525.00M in Q1 2026.
- How has Biogen's 2028 changed year-over-year?
- Biogen's 2028 decreased by 12.5% year-over-year, from $600.00M to $525.00M.
- What is the long-term trend for Biogen's 2028?
- Over 3 years (2020 to 2023), Biogen's 2028 has grown at a 29.8% compound annual growth rate (CAGR), from $215.00M to $470.00M.
- What does 2028 mean?
- The expected non-cash expense for acquired intangible assets in the year 2028.